nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—Jaundice cholestatic—Epirubicin—testicular cancer	0.00335	0.00335	CcSEcCtD
Prochlorperazine—Dysphagia—Etoposide—testicular cancer	0.00329	0.00329	CcSEcCtD
Prochlorperazine—Blood disorder—Doxorubicin—testicular cancer	0.00326	0.00326	CcSEcCtD
Prochlorperazine—Liver injury—Doxorubicin—testicular cancer	0.00324	0.00324	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Vinblastine—testicular cancer	0.00322	0.00322	CcSEcCtD
Prochlorperazine—Erythema—Dactinomycin—testicular cancer	0.00317	0.00317	CcSEcCtD
Prochlorperazine—Erythema multiforme—Ifosfamide—testicular cancer	0.00316	0.00316	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Methotrexate—testicular cancer	0.00314	0.00314	CcSEcCtD
Prochlorperazine—Dyskinesia—Epirubicin—testicular cancer	0.00313	0.00313	CcSEcCtD
Prochlorperazine—Pancytopenia—Etoposide—testicular cancer	0.00313	0.00313	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Doxorubicin—testicular cancer	0.0031	0.0031	CcSEcCtD
Prochlorperazine—Amenorrhoea—Doxorubicin—testicular cancer	0.0031	0.0031	CcSEcCtD
Prochlorperazine—Leukopenia—Bleomycin—testicular cancer	0.00304	0.00304	CcSEcCtD
Prochlorperazine—Gait disturbance—Epirubicin—testicular cancer	0.00301	0.00301	CcSEcCtD
Prochlorperazine—Arrhythmia—Ifosfamide—testicular cancer	0.00298	0.00298	CcSEcCtD
Prochlorperazine—Cough—Bleomycin—testicular cancer	0.00297	0.00297	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Methotrexate—testicular cancer	0.00295	0.00295	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Epirubicin—testicular cancer	0.00294	0.00294	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Epirubicin—testicular cancer	0.00294	0.00294	CcSEcCtD
Prochlorperazine—Dermatitis contact—Epirubicin—testicular cancer	0.00291	0.00291	CcSEcCtD
Prochlorperazine—Erythema—Ifosfamide—testicular cancer	0.00291	0.00291	CcSEcCtD
Prochlorperazine—Dyskinesia—Doxorubicin—testicular cancer	0.0029	0.0029	CcSEcCtD
Prochlorperazine—Coma—Methotrexate—testicular cancer	0.00287	0.00287	CcSEcCtD
Prochlorperazine—Jaundice—Etoposide—testicular cancer	0.00286	0.00286	CcSEcCtD
Prochlorperazine—Urticaria—Chlorambucil—testicular cancer	0.00285	0.00285	CcSEcCtD
Prochlorperazine—Leukopenia—Dactinomycin—testicular cancer	0.00284	0.00284	CcSEcCtD
Prochlorperazine—Body temperature increased—Chlorambucil—testicular cancer	0.00283	0.00283	CcSEcCtD
Prochlorperazine—Gynaecomastia—Methotrexate—testicular cancer	0.00281	0.00281	CcSEcCtD
Prochlorperazine—Constipation—Vinblastine—testicular cancer	0.00281	0.00281	CcSEcCtD
Prochlorperazine—Gait disturbance—Doxorubicin—testicular cancer	0.00279	0.00279	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Bleomycin—testicular cancer	0.00277	0.00277	CcSEcCtD
Prochlorperazine—Oedema—Bleomycin—testicular cancer	0.00277	0.00277	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Epirubicin—testicular cancer	0.00276	0.00276	CcSEcCtD
Prochlorperazine—Infection—Bleomycin—testicular cancer	0.00276	0.00276	CcSEcCtD
Prochlorperazine—Agranulocytosis—Etoposide—testicular cancer	0.00274	0.00274	CcSEcCtD
Prochlorperazine—Vision blurred—Ifosfamide—testicular cancer	0.00274	0.00274	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Doxorubicin—testicular cancer	0.00272	0.00272	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Doxorubicin—testicular cancer	0.00272	0.00272	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Bleomycin—testicular cancer	0.00272	0.00272	CcSEcCtD
Prochlorperazine—Dermatitis contact—Doxorubicin—testicular cancer	0.00269	0.00269	CcSEcCtD
Prochlorperazine—Coma—Epirubicin—testicular cancer	0.00269	0.00269	CcSEcCtD
Prochlorperazine—Agitation—Ifosfamide—testicular cancer	0.00267	0.00267	CcSEcCtD
Prochlorperazine—Angioedema—Ifosfamide—testicular cancer	0.00265	0.00265	CcSEcCtD
Prochlorperazine—Hypersensitivity—Chlorambucil—testicular cancer	0.00264	0.00264	CcSEcCtD
Prochlorperazine—Leukopenia—Ifosfamide—testicular cancer	0.0026	0.0026	CcSEcCtD
Prochlorperazine—Photosensitivity—Methotrexate—testicular cancer	0.0026	0.0026	CcSEcCtD
Prochlorperazine—Hypotension—Bleomycin—testicular cancer	0.00259	0.00259	CcSEcCtD
Prochlorperazine—Oedema—Dactinomycin—testicular cancer	0.00259	0.00259	CcSEcCtD
Prochlorperazine—Infection—Dactinomycin—testicular cancer	0.00257	0.00257	CcSEcCtD
Prochlorperazine—Arrhythmia—Cisplatin—testicular cancer	0.00257	0.00257	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Doxorubicin—testicular cancer	0.00256	0.00256	CcSEcCtD
Prochlorperazine—Pruritus—Chlorambucil—testicular cancer	0.00254	0.00254	CcSEcCtD
Prochlorperazine—Cough—Ifosfamide—testicular cancer	0.00254	0.00254	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Dactinomycin—testicular cancer	0.00253	0.00253	CcSEcCtD
Prochlorperazine—Convulsion—Ifosfamide—testicular cancer	0.00252	0.00252	CcSEcCtD
Prochlorperazine—Erythema—Cisplatin—testicular cancer	0.0025	0.0025	CcSEcCtD
Prochlorperazine—Erythema multiforme—Etoposide—testicular cancer	0.00249	0.00249	CcSEcCtD
Prochlorperazine—Coma—Doxorubicin—testicular cancer	0.00249	0.00249	CcSEcCtD
Prochlorperazine—Dyspnoea—Bleomycin—testicular cancer	0.00247	0.00247	CcSEcCtD
Prochlorperazine—Photosensitivity—Epirubicin—testicular cancer	0.00243	0.00243	CcSEcCtD
Prochlorperazine—Hypersensitivity—Vinblastine—testicular cancer	0.00242	0.00242	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Methotrexate—testicular cancer	0.00242	0.00242	CcSEcCtD
Prochlorperazine—Muscle spasms—Cisplatin—testicular cancer	0.00241	0.00241	CcSEcCtD
Prochlorperazine—Eczema—Epirubicin—testicular cancer	0.00238	0.00238	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Ifosfamide—testicular cancer	0.00237	0.00237	CcSEcCtD
Prochlorperazine—Oedema—Ifosfamide—testicular cancer	0.00237	0.00237	CcSEcCtD
Prochlorperazine—Vision blurred—Cisplatin—testicular cancer	0.00236	0.00236	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00236	0.00236	CcSEcCtD
Prochlorperazine—Infection—Ifosfamide—testicular cancer	0.00236	0.00236	CcSEcCtD
Prochlorperazine—Tremor—Cisplatin—testicular cancer	0.00235	0.00235	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Ifosfamide—testicular cancer	0.00232	0.00232	CcSEcCtD
Prochlorperazine—Skin disorder—Ifosfamide—testicular cancer	0.0023	0.0023	CcSEcCtD
Prochlorperazine—Increased appetite—Epirubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00226	0.00226	CcSEcCtD
Prochlorperazine—Photosensitivity—Doxorubicin—testicular cancer	0.00225	0.00225	CcSEcCtD
Prochlorperazine—Leukopenia—Cisplatin—testicular cancer	0.00224	0.00224	CcSEcCtD
Prochlorperazine—Hypotension—Ifosfamide—testicular cancer	0.00222	0.00222	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00221	0.00221	CcSEcCtD
Prochlorperazine—Muscle spasms—Etoposide—testicular cancer	0.00221	0.00221	CcSEcCtD
Prochlorperazine—Urticaria—Bleomycin—testicular cancer	0.0022	0.0022	CcSEcCtD
Prochlorperazine—Eczema—Doxorubicin—testicular cancer	0.0022	0.0022	CcSEcCtD
Prochlorperazine—Body temperature increased—Bleomycin—testicular cancer	0.00219	0.00219	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Epirubicin—testicular cancer	0.00219	0.00219	CcSEcCtD
Prochlorperazine—Dizziness—Vinblastine—testicular cancer	0.00217	0.00217	CcSEcCtD
Prochlorperazine—Convulsion—Cisplatin—testicular cancer	0.00217	0.00217	CcSEcCtD
Prochlorperazine—Dyspnoea—Ifosfamide—testicular cancer	0.00211	0.00211	CcSEcCtD
Prochlorperazine—Somnolence—Ifosfamide—testicular cancer	0.00211	0.00211	CcSEcCtD
Prochlorperazine—Increased appetite—Doxorubicin—testicular cancer	0.0021	0.0021	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Prochlorperazine—Headache—Vinblastine—testicular cancer	0.00206	0.00206	CcSEcCtD
Prochlorperazine—Leukopenia—Etoposide—testicular cancer	0.00205	0.00205	CcSEcCtD
Prochlorperazine—Body temperature increased—Dactinomycin—testicular cancer	0.00205	0.00205	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Cisplatin—testicular cancer	0.00204	0.00204	CcSEcCtD
Prochlorperazine—Oedema—Cisplatin—testicular cancer	0.00204	0.00204	CcSEcCtD
Prochlorperazine—Hypersensitivity—Bleomycin—testicular cancer	0.00204	0.00204	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00204	0.00204	CcSEcCtD
Prochlorperazine—Cardiac arrest—Epirubicin—testicular cancer	0.00203	0.00203	CcSEcCtD
Prochlorperazine—Infection—Cisplatin—testicular cancer	0.00203	0.00203	CcSEcCtD
Prochlorperazine—Constipation—Ifosfamide—testicular cancer	0.00203	0.00203	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Doxorubicin—testicular cancer	0.00202	0.00202	CcSEcCtD
Prochlorperazine—Cough—Etoposide—testicular cancer	0.002	0.002	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Cisplatin—testicular cancer	0.002	0.002	CcSEcCtD
Prochlorperazine—Convulsion—Etoposide—testicular cancer	0.00199	0.00199	CcSEcCtD
Prochlorperazine—Skin disorder—Cisplatin—testicular cancer	0.00199	0.00199	CcSEcCtD
Prochlorperazine—Asthma—Methotrexate—testicular cancer	0.00197	0.00197	CcSEcCtD
Prochlorperazine—Pruritus—Bleomycin—testicular cancer	0.00196	0.00196	CcSEcCtD
Prochlorperazine—Eosinophilia—Methotrexate—testicular cancer	0.00195	0.00195	CcSEcCtD
Prochlorperazine—Hypotension—Cisplatin—testicular cancer	0.00191	0.00191	CcSEcCtD
Prochlorperazine—Hypersensitivity—Dactinomycin—testicular cancer	0.00191	0.00191	CcSEcCtD
Prochlorperazine—Urticaria—Ifosfamide—testicular cancer	0.00188	0.00188	CcSEcCtD
Prochlorperazine—Cardiac arrest—Doxorubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Prochlorperazine—Body temperature increased—Ifosfamide—testicular cancer	0.00187	0.00187	CcSEcCtD
Prochlorperazine—Pancytopenia—Methotrexate—testicular cancer	0.00187	0.00187	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Etoposide—testicular cancer	0.00187	0.00187	CcSEcCtD
Prochlorperazine—Infection—Etoposide—testicular cancer	0.00186	0.00186	CcSEcCtD
Prochlorperazine—Asthma—Epirubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Prochlorperazine—Influenza—Epirubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Prochlorperazine—Dysphagia—Epirubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Etoposide—testicular cancer	0.00183	0.00183	CcSEcCtD
Prochlorperazine—Eosinophilia—Epirubicin—testicular cancer	0.00183	0.00183	CcSEcCtD
Prochlorperazine—Dyspnoea—Cisplatin—testicular cancer	0.00182	0.00182	CcSEcCtD
Prochlorperazine—Skin disorder—Etoposide—testicular cancer	0.00182	0.00182	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Methotrexate—testicular cancer	0.00182	0.00182	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Methotrexate—testicular cancer	0.0018	0.0018	CcSEcCtD
Prochlorperazine—Drowsiness—Methotrexate—testicular cancer	0.00176	0.00176	CcSEcCtD
Prochlorperazine—Pancytopenia—Epirubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Prochlorperazine—Hypotension—Etoposide—testicular cancer	0.00175	0.00175	CcSEcCtD
Prochlorperazine—Rash—Bleomycin—testicular cancer	0.00175	0.00175	CcSEcCtD
Prochlorperazine—Dermatitis—Bleomycin—testicular cancer	0.00175	0.00175	CcSEcCtD
Prochlorperazine—Hypersensitivity—Ifosfamide—testicular cancer	0.00175	0.00175	CcSEcCtD
Prochlorperazine—Asthma—Doxorubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Prochlorperazine—Influenza—Doxorubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Prochlorperazine—Dysphagia—Doxorubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Prochlorperazine—Eosinophilia—Doxorubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Epirubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Prochlorperazine—Weight increased—Epirubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Prochlorperazine—Pruritus—Ifosfamide—testicular cancer	0.00168	0.00168	CcSEcCtD
Prochlorperazine—Dyspnoea—Etoposide—testicular cancer	0.00167	0.00167	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Epirubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Prochlorperazine—Somnolence—Etoposide—testicular cancer	0.00166	0.00166	CcSEcCtD
Prochlorperazine—Drowsiness—Epirubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Prochlorperazine—Agranulocytosis—Methotrexate—testicular cancer	0.00164	0.00164	CcSEcCtD
Prochlorperazine—Rash—Dactinomycin—testicular cancer	0.00163	0.00163	CcSEcCtD
Prochlorperazine—Pancytopenia—Doxorubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Prochlorperazine—Body temperature increased—Cisplatin—testicular cancer	0.00162	0.00162	CcSEcCtD
Prochlorperazine—Jaundice—Epirubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Prochlorperazine—Constipation—Etoposide—testicular cancer	0.0016	0.0016	CcSEcCtD
Prochlorperazine—Dizziness—Ifosfamide—testicular cancer	0.00157	0.00157	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Prochlorperazine—Weight increased—Doxorubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Doxorubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Prochlorperazine—Agranulocytosis—Epirubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Prochlorperazine—Drowsiness—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Prochlorperazine—Hypersensitivity—Cisplatin—testicular cancer	0.00151	0.00151	CcSEcCtD
Prochlorperazine—Rash—Ifosfamide—testicular cancer	0.00149	0.00149	CcSEcCtD
Prochlorperazine—Dermatitis—Ifosfamide—testicular cancer	0.00149	0.00149	CcSEcCtD
Prochlorperazine—Erythema multiforme—Methotrexate—testicular cancer	0.00149	0.00149	CcSEcCtD
Prochlorperazine—Urticaria—Etoposide—testicular cancer	0.00149	0.00149	CcSEcCtD
Prochlorperazine—Jaundice—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Prochlorperazine—Body temperature increased—Etoposide—testicular cancer	0.00148	0.00148	CcSEcCtD
Prochlorperazine—Oedema peripheral—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Prochlorperazine—Agranulocytosis—Doxorubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Prochlorperazine—Erythema multiforme—Epirubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Prochlorperazine—Hypersensitivity—Etoposide—testicular cancer	0.00138	0.00138	CcSEcCtD
Prochlorperazine—Erythema—Methotrexate—testicular cancer	0.00137	0.00137	CcSEcCtD
Prochlorperazine—Oedema peripheral—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Prochlorperazine—Pruritus—Etoposide—testicular cancer	0.00132	0.00132	CcSEcCtD
Prochlorperazine—Arrhythmia—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Prochlorperazine—Vision blurred—Methotrexate—testicular cancer	0.0013	0.0013	CcSEcCtD
Prochlorperazine—Erythema multiforme—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Prochlorperazine—Rash—Cisplatin—testicular cancer	0.00129	0.00129	CcSEcCtD
Prochlorperazine—Dermatitis—Cisplatin—testicular cancer	0.00129	0.00129	CcSEcCtD
Prochlorperazine—Erythema—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Prochlorperazine—Nervousness—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Prochlorperazine—Dizziness—Etoposide—testicular cancer	0.00124	0.00124	CcSEcCtD
Prochlorperazine—Muscle spasms—Epirubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Prochlorperazine—Leukopenia—Methotrexate—testicular cancer	0.00123	0.00123	CcSEcCtD
Prochlorperazine—Arrhythmia—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Prochlorperazine—Vision blurred—Epirubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Prochlorperazine—Cough—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Prochlorperazine—Convulsion—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Prochlorperazine—Erythema—Doxorubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Prochlorperazine—Agitation—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Prochlorperazine—Rash—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Prochlorperazine—Dermatitis—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Prochlorperazine—Headache—Etoposide—testicular cancer	0.00117	0.00117	CcSEcCtD
Prochlorperazine—Nervousness—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Prochlorperazine—Leukopenia—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Prochlorperazine—Muscle spasms—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Prochlorperazine—Cough—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Prochlorperazine—Vision blurred—Doxorubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Prochlorperazine—Convulsion—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Prochlorperazine—Infection—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Methotrexate—testicular cancer	0.0011	0.0011	CcSEcCtD
Prochlorperazine—Agitation—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Prochlorperazine—Skin disorder—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Prochlorperazine—Dry mouth—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Prochlorperazine—Leukopenia—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Prochlorperazine—Oedema—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Prochlorperazine—Hypotension—Methotrexate—testicular cancer	0.00105	0.00105	CcSEcCtD
Prochlorperazine—Infection—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Prochlorperazine—Cough—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Prochlorperazine—Convulsion—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Prochlorperazine—Skin disorder—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Prochlorperazine—Insomnia—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Prochlorperazine—Dyspnoea—Methotrexate—testicular cancer	0.001	0.001	CcSEcCtD
Prochlorperazine—Somnolence—Methotrexate—testicular cancer	0.000997	0.000997	CcSEcCtD
Prochlorperazine—Dry mouth—Doxorubicin—testicular cancer	0.000991	0.000991	CcSEcCtD
Prochlorperazine—Hypotension—Epirubicin—testicular cancer	0.000981	0.000981	CcSEcCtD
Prochlorperazine—Oedema—Doxorubicin—testicular cancer	0.000971	0.000971	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000971	0.000971	CcSEcCtD
Prochlorperazine—Infection—Doxorubicin—testicular cancer	0.000965	0.000965	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000951	0.000951	CcSEcCtD
Prochlorperazine—Insomnia—Epirubicin—testicular cancer	0.000949	0.000949	CcSEcCtD
Prochlorperazine—Skin disorder—Doxorubicin—testicular cancer	0.000943	0.000943	CcSEcCtD
Prochlorperazine—Dyspnoea—Epirubicin—testicular cancer	0.000936	0.000936	CcSEcCtD
Prochlorperazine—Somnolence—Epirubicin—testicular cancer	0.000933	0.000933	CcSEcCtD
Prochlorperazine—Hypotension—Doxorubicin—testicular cancer	0.000908	0.000908	CcSEcCtD
Prochlorperazine—Constipation—Epirubicin—testicular cancer	0.000898	0.000898	CcSEcCtD
Prochlorperazine—Urticaria—Methotrexate—testicular cancer	0.000891	0.000891	CcSEcCtD
Prochlorperazine—Body temperature increased—Methotrexate—testicular cancer	0.000887	0.000887	CcSEcCtD
Prochlorperazine—Insomnia—Doxorubicin—testicular cancer	0.000878	0.000878	CcSEcCtD
Prochlorperazine—Dyspnoea—Doxorubicin—testicular cancer	0.000866	0.000866	CcSEcCtD
Prochlorperazine—Somnolence—Doxorubicin—testicular cancer	0.000863	0.000863	CcSEcCtD
Prochlorperazine—Urticaria—Epirubicin—testicular cancer	0.000834	0.000834	CcSEcCtD
Prochlorperazine—Constipation—Doxorubicin—testicular cancer	0.000831	0.000831	CcSEcCtD
Prochlorperazine—Body temperature increased—Epirubicin—testicular cancer	0.00083	0.00083	CcSEcCtD
Prochlorperazine—Hypersensitivity—Methotrexate—testicular cancer	0.000826	0.000826	CcSEcCtD
Prochlorperazine—Pruritus—Methotrexate—testicular cancer	0.000794	0.000794	CcSEcCtD
Prochlorperazine—Hypersensitivity—Epirubicin—testicular cancer	0.000773	0.000773	CcSEcCtD
Prochlorperazine—Urticaria—Doxorubicin—testicular cancer	0.000772	0.000772	CcSEcCtD
Prochlorperazine—Body temperature increased—Doxorubicin—testicular cancer	0.000768	0.000768	CcSEcCtD
Prochlorperazine—Pruritus—Epirubicin—testicular cancer	0.000743	0.000743	CcSEcCtD
Prochlorperazine—Dizziness—Methotrexate—testicular cancer	0.000742	0.000742	CcSEcCtD
Prochlorperazine—Hypersensitivity—Doxorubicin—testicular cancer	0.000716	0.000716	CcSEcCtD
Prochlorperazine—Rash—Methotrexate—testicular cancer	0.000707	0.000707	CcSEcCtD
Prochlorperazine—Dermatitis—Methotrexate—testicular cancer	0.000707	0.000707	CcSEcCtD
Prochlorperazine—Headache—Methotrexate—testicular cancer	0.000703	0.000703	CcSEcCtD
Prochlorperazine—Dizziness—Epirubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Prochlorperazine—Pruritus—Doxorubicin—testicular cancer	0.000687	0.000687	CcSEcCtD
Prochlorperazine—Rash—Epirubicin—testicular cancer	0.000662	0.000662	CcSEcCtD
Prochlorperazine—Dermatitis—Epirubicin—testicular cancer	0.000661	0.000661	CcSEcCtD
Prochlorperazine—Headache—Epirubicin—testicular cancer	0.000658	0.000658	CcSEcCtD
Prochlorperazine—Dizziness—Doxorubicin—testicular cancer	0.000642	0.000642	CcSEcCtD
Prochlorperazine—Rash—Doxorubicin—testicular cancer	0.000612	0.000612	CcSEcCtD
Prochlorperazine—Dermatitis—Doxorubicin—testicular cancer	0.000612	0.000612	CcSEcCtD
Prochlorperazine—Headache—Doxorubicin—testicular cancer	0.000608	0.000608	CcSEcCtD
